Publication Name	World Journal of Gastroenterology
Manuscript ID	32968
Country	Norway

Received	2017-02-01 12:43
Peer-Review Started	2017-02-02 13:36
To Make the First Decision	2017-03-03 10:07
Return for Revision	2017-03-07 10:33
Revised	2017-03-17 18:19
Second Decision	2017-04-14 17:35
Accepted by Journal Editor-in-Chief	2017-04-17 03:28
Accepted by Company Editor-in-Chief	2017-04-21 15:20
Articles in Press	2017-04-21 15:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-05-03 19:20
Publish the Manuscript Online	2017-06-07 07:22

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Editorial
Article Title	Role of surgery in pancreatic cancer
Manuscript Source	Invited Manuscript
All Author List	Trond A Buanes
Funding Agency and Grant Number
Corresponding Author	Trond A Buanes, MD, PhD, Professor, Department of Hepato-Pancreatico-Biliary Surgery, Oslo University Hospital, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Nydalen, Pb 4956 N-0424 Oslo, Norway. trond.buanes@medisin.uio.no
Key Words	Adjuvant chemotherapy; Neoadjuvant chemotherapy; Metastasis; Pancreatic cancer; Patient reported outcome; Survival
Core Tip	Both surgery and chemotherapy are mandatory in multimodal treatment of pancreatic cancer to obtain curative potential. The sequence of interventions is a core question: Upfront surgery or neoadjuvant chemotherapy with subsequent resection. Also the role of extended operations incorporating reconstruction of major mesenteric vessels and multi­visceral resections is a matter of ongoing evaluation. The current direction of this development is increasing prognostic importance of surgical resection.
Publish Date	2017-06-07 07:22
Citation	Buanes TA. Role of surgery in pancreatic cancer. World J Gastroenterol 2017; 23(21): 3765-3770
URL	http://www.wjgnet.com/1007-9327/full/v23/i21/3765.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i21.3765

Full Article (PDF)	WJG-23-3765.pdf
Full Article (Word)	WJG-23-3765.doc
Manuscript File	32968-Review.docx
Answering Reviewers	32968-Answering reviewers.pdf
Audio Core Tip	32968-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	32968-Conflict-of-interest statement.pdf
Copyright License Agreement	32968-Copyright assignment.pdf
Peer-review Report	32968-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	32968-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	32968-Scientific misconduct check.pdf
Scientific Editor Work List	32968-Scientific editor work list.pdf